John Koconis - 15 Apr 2023 Form 4 Insider Report for Timber Pharmaceuticals, Inc.

Role
CEO & Chairman
Signature
/s/ Joseph Lucchese, Power of Attorney
Issuer symbol
N/A
Transactions as of
15 Apr 2023
Net transactions value
$0
Form type
4
Filing time
18 Apr 2023, 11:43:34 UTC
Previous filing
19 Apr 2022
Next filing
22 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMBR Stock Option (right to buy) Award $0 +45,010 $0.000000 45,010 15 Apr 2023 Common Stock 45,010 $1.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the options vest on April 15, 2024, and the remaining shares will become exercisable in 36 equal monthly installments beginning on May 15, 2024, as long as the Reporting Person remains in continuous service with Timber Pharmaceuticals, Inc. through each vesting date.